Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar-Apr;19(2):233-235.
doi: 10.1097/ADM.0000000000001396. Epub 2024 Nov 8.

Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit

Cassandra Trammel  1 , Vahid Azimi, Bridgit Crews, Stephen Roper, Nandini Raghuraman, Ebony B Carter, Antonina Frolova, Anthony O Odibo, Megan Lawlor, Jeannie C Kelly
Affiliations

Xylazine Positivity in Opioid-positive Drug Screens on an Inpatient Labor Unit

Cassandra Trammel et al. J Addict Med. 2025 Mar-Apr.

Abstract

Objective: Untreated opioid use disorder (OUD) is associated with significant morbidity in pregnancy. Recent reports have highlighted the rise of xylazine in the nonprescribed fentanyl supply. The frequency with which pregnant people with OUD are exposed to xylazine has not been characterized. We sought to describe the rate of xylazine detection in urine drug screens (UDS) from pregnant people admitted to a labor unit.

Methods: We performed a cross sectional study of all UDS results from an inpatient obstetric unit at an urban tertiary care center from December 2022, when xylazine was added to the detection panel, through July 2023. We perform universal verbal drug screening, with subsequent urine drug screening only performed after a positive verbal screen and consent. The trend of opioid-positive urine drug screens also positive for xylazine from December to July was measured with the Cochran-Armitage test.

Results: Of 5662 people admitted to Labor and Delivery during the study period, 138 UDS were sent for 123 unique individuals. Ninety-eight (71%) of UDS were positive for nonprescribed substances. Of positive UDS, 36 (37%) were positive for nonprescribed opioids, and of these, 17 (47.2%) were positive for xylazine among 14 pregnant people. The trend of UDS positive for opioids that were also positive for xylazine increased significantly over time ( P = 0.030), from 0% in December 2022 to 100% in July 2023.

Conclusions: Over 8 months, xylazine positivity significantly increased in UDSs positive for nonprescribed opioids in an urban Midwestern hospital. These results underscore the critical need to study the impact of xylazine on obstetric outcomes.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Holt AC, Schwope DM, Le K, et al. Widespread distribution of xylazine detected throughout the United States in healthcare patient samples. J Addict Med . 2023;17(4):468–470.
    1. Jansen CAM, Lowe KC, Nathanielsz PW. The effects of xylazine on uterine activity, fetal and maternal oxygenation, cardiovascular function, and fetal breathing. Am J Obstet Gynecol . 1984;184(4):386–390.
    1. Spadaro A, O'Connor K, Lakamana S, et al. Self-reported xylazine experiences: a mixed-methods study of Reddit subscribers. J Addict Med . 2023;17(6):691–694.
    1. McFadden R, Wallace-Keeshen S, Petrillo Straub K, et al. xylazine-associated wounds: clinical experience from a low-barrier wound care clinic in Philadelphia. J Addict Med . 2024;18(1):9–12.
    1. Alexander RS, Canver BR, Sue KL, et al. Xylazine and overdoses: trends, concerns, and recommendations. Am J Public Health . 2022;112(8):1212–1216.